Delivery Order SPE2DB24D2109-SPE2DB24FHVWR
Award Date
7/24/24
Potential Completion Date
7/25/24
Potential Value
$60K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GEMTESA 75 MG TABLET 90S. The contract has a ceiling value of $4,587.85 and an ultimate completion date of August 5, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation. This award is likely part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed-price, with a ceiling value of $20,272.59 and a period of performance through August 15, 2024. There is no set-aside designation noted for this award. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of medical supplies and prescription drugs to various...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of GEMTESA 75 MG TABLET 90S. The firm-fixed-price contract has a ceiling value of $1,020.90 and an ultimate completion date of August 14, 2024. The contract was awarded on August 13, 2024 and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GEMTESA 75 MG TABLET 30S. The contract has a ceiling value of $4,494.91 and a completion date of March 13, 2025. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $43,318.33 and a completion date of May 16, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GEMTESA 75 MG TABLET 90S. The delivery order is valued at $8,058.59 and has a completion date of September 25, 2024. It is a firm fixed-price contract and is not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. The $7,572.53 contract has an ultimate completion date of November 24, 2023. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a wide range of pharmaceutical products...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract is a firm-fixed price delivery order with a ceiling value of $32,313.82 and a period of performance through August 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these prescription drug products to support military treatment facilities and other government healthcare...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $7,613.21 and a period of performance through June 17, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of GEMTESA 75 MG TABLET 30S, a pharmaceutical product, with a total ceiling value of $10,083.35 and a completion date of May 23, 2024. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...